U.S. Department of Health and Human Services

Neonatal Acute Kidney Injury Workshop

4/9/2013 7:30 AM
4/9/2013 5:30 PM
​For logistical questions, please contact
Ms. Mary Allen at mallen@scgcorp.com
or (301) 670-4990.
Executive Plaza North

Event Details

Due to the limited size of the meeting room, there is no onsite registration for this meeting. If the online registration is closed, that means that we have hit the maximum number of people and cannot register anybody else. Thank you.

Meeting Purpose:

The purpose of this conference is to: (1) review the state-of-the-art knowledge of acute kidney injury (AKI) in neonates; and (2) determine the feasibility of studying this group in an organized prospective manner. This conference will bring together experts from the fields of pediatric nephrology, neonatology, general pediatrics, industry, and professional organizations to get a broad perspective on the issues to be considered.

Meeting Planning Committee:

Marva Moxey-Mims, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Paul Kimmel, M.D.

Rosemary Higgins, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Tonse Raju, M.D.

Stuart Goldstein, M.D.
Cincinnati Children’s Hospital Medical Center

Timothy Bunchman, M.D.
Virginia Commonwealth University

David Askenazi, M.D.
University of Alabama at Birmingham

Namasivayam Ambalavanan, M.D.
University of Alabama at Birmingham

Catherine Morgan, M.D., M.Sc.
University of Alberta

P. Brian Smith, M.D., M.P.H., M.H.S.
Duke University Medical Center

Matthew M. Laughon, M.D., M.P.H.
University of North Carolina, Chapel Hill​


Tuesday, April 9, 2013

7:30 a.m.


Session 1: Neonatal AKI Epidemiology Today

8:00 a.m. AKI Definitions:Do They Make Sense in Neonates?
Michael Zappitelli, M.D.
8:15 a.m. Risk Factors for AKI
Namasivayam Ambalavanan, M.D.
8:30 a.m. Outcomes in Neonatal AKI
David Askenazi, M.D.
Session 2: Neonatal AKI From the Bench to Bedside
8:45 a.m. Impact on the Developing Nephron
Patrick Brophy, M.D.
9:00 a.m. Biomarkers
Stuart Goldstein, M.D.
9:15 a.m. What Do We Know About Long-term Kidney Outcomes in Neonatal Survivors?
Cherry Mammen, M.D.
9:30 a.m. What Do We Know About Long-term Neonatal Cardiac Surgery Associated AKI Outcomes?
Catherine Morgan, M.D.
9:45 a.m. Break

Session 3: How Will We Study Long-term Neonatal AKI Outcomes: Lessons From Other Neonatal Studies

10:15 a.m. The PROP Study
James Greenberg, M.D.
10:35 a.m. The Neonatal Network
Rosemary Higgins, M.D.
10:55 a.m. The Kaiser Permanente Experience
Michael Kuzniewicz, M.D.
11:15 a.m. The Pediatrix Experience
P. Brian Smith, M.D.
Working Lunch/Breakout Sessions
11:45 a.m. Group 1:Developing the Neonatal AKI Definition
Group Leaders: Drs. Michael Zappitelli and Namasivayam Ambalavanan
11:45 a.m. Group 2:Developing the Feasible Neonatal AKI Study
Group Leaders: Drs. Catherine Morgan and Rosemary Higgins
11:45 a.m. Group 3:Challenges to Long-term Neonatal AKI Followup From NICU Discharge to 6 Years of Age
Group Leaders: Drs. David Askenazi and Matthew Laughon
2:15 p.m. Group 1
3:00 p.m. Group 2
3:45 p.m. Group 3
4:30 p.m. Wrap-up and Assignments
5:00 p.m. Adjournment


​Directions are currently unavailable.


​​Minutes are currently unavailable.


​​Attendees are currently unavailable.


​​Abstracts are currently unavailable.


  • 6130 Executive Boulevard
  • MD 20852


​For logistical questions, please contact
Ms. Mary Allen at mallen@scgcorp.com
or (301) 670-4990.